News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
5,099 Results
Type
Article (292)
Company Profile (1)
Press Release (4806)
Section
Business (1320)
Career Advice (2)
Deals (228)
Drug Delivery (3)
Drug Development (449)
Employer Resources (1)
FDA (128)
Job Trends (158)
News (2149)
Policy (208)
Tag
Academia (19)
Allergies (1)
Alliances (369)
Alzheimer's disease (11)
Antibody-drug conjugate (ADC) (21)
Approvals (141)
Artificial intelligence (2)
Autoimmune disease (2)
Bankruptcy (2)
Best Places to Work (149)
Biosimilars (2)
Breast cancer (39)
Cancer (89)
Cardiovascular disease (1)
Career advice (2)
CAR-T (8)
Cell therapy (12)
Clinical research (458)
Collaboration (20)
Compensation (1)
COVID-19 (9)
C-suite (6)
Cystic fibrosis (1)
Data (84)
Depression (1)
Diabetes (4)
Diagnostics (144)
Diversity, equity & inclusion (1)
Drug discovery (1)
Drug pricing (1)
Duchenne muscular dystrophy (3)
Earnings (617)
Employer resources (1)
Events (647)
Executive appointments (9)
FDA (166)
Funding (8)
Generative AI (1)
Gene therapy (3)
GLP-1 (2)
Government (24)
Guidances (6)
Healthcare (105)
Immunology and inflammation (7)
Infectious disease (9)
Inflammatory bowel disease (3)
Intellectual property (7)
Interviews (1)
IPO (97)
Job creations (15)
Job search strategy (2)
Layoffs (3)
Legal (52)
Lung cancer (13)
Lymphoma (7)
Manufacturing (9)
Medical device (67)
Medtech (67)
Mergers & acquisitions (135)
Metabolic disorders (5)
Multiple sclerosis (10)
Neurodegenerative disease (5)
Neuropsychiatric disorders (1)
Neuroscience (37)
NextGen: Class of 2026 (76)
Non-profit (64)
Obesity (1)
Opinion (1)
Ovarian cancer (3)
Patents (9)
Patient recruitment (3)
People (328)
Phase 1 (127)
Phase 2 (172)
Phase 3 (210)
Pipeline (76)
Postmarket research (4)
Preclinical (51)
Radiopharmaceuticals (1)
Rare diseases (7)
Real estate (29)
Regulatory (169)
Reports (3)
Research institute (21)
Resumes & cover letters (1)
Schizophrenia (11)
Series B (2)
Spinal muscular atrophy (2)
Startups (24)
Stomach cancer (2)
Supply chain (1)
Vaccines (2)
Venture capital (1)
Date
Today (1)
Last 7 days (5)
Last 30 days (26)
Last 365 days (331)
2026 (37)
2025 (330)
2024 (381)
2023 (325)
2022 (431)
2021 (360)
2020 (291)
2019 (302)
2018 (224)
2017 (248)
2016 (226)
2015 (273)
2014 (203)
2013 (232)
2012 (243)
2011 (166)
2010 (141)
Location
Africa (7)
Arizona (1)
Asia (293)
Australia (26)
California (132)
Canada (29)
China (6)
Colorado (2)
Connecticut (6)
Delaware (24)
Europe (542)
Florida (3)
Illinois (6)
Japan (64)
Maryland (33)
Massachusetts (15)
New Jersey (60)
New York (4)
North Carolina (6)
Northern California (72)
Ohio (2)
Pennsylvania (29)
South America (13)
Southern California (55)
Texas (43)
United States (387)
Utah (14)
Virginia (4)
Washington State (5)
5,099 Results for "nx prenatal".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care
January 8, 2026
·
7 min read
Press Releases
Nurix Therapeutics Presents New Data from the Phase 1 Trial of Bexobrutideg (NX-5948) in Waldenström Macroglobulinemia at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition
December 8, 2025
·
8 min read
Press Releases
Pulsenmore Receives FDA De Novo Marketing Authorization for Home-Use Prenatal Ultrasound, Pioneering a New Era of Prenatal Care in the U.S.
November 4, 2025
·
3 min read
Press Releases
Nurix Therapeutics Presents New Translational Data from First-in-Human Clinical Trial of Oral CBL-B Inhibitor NX-1607 Demonstrating Immune Activation and Tumor Microenvironment Remodeling
November 10, 2025
·
6 min read
Press Releases
Nurix Therapeutics Announces Webcast to Review New and Updated Data from the Phase 1 Clinical Trial of BTK Degrader Bexobrutideg (NX-5948) To Be Presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition
December 2, 2025
·
4 min read
Press Releases
Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition
December 8, 2025
·
11 min read
Press Releases
Nurix Therapeutics Reports New Clinical Data from First-in-Class Oral CBL-B Inhibitor, NX-1607, Demonstrating Single-Agent Activity Across Multiple Tumor Types at the European Society for Medical Oncology (ESMO) Congress
October 20, 2025
·
8 min read
NX Development Corp. Enrolls First Patient in OVA-302 Study After FDA Orphan Designation for Gleolan(R)
NX Development Corp. (NXDC) is pleased to announce a significant milestone.
June 21, 2024
·
1 min read
Press Releases
European Medicines Agency Grants Bexobrutideg (NX-5948) Orphan Drug Designation for the Treatment of Lymphoplasmacytic Lymphoma, also Known as Waldenström Macroglobulinemia
July 8, 2025
·
6 min read
Press Releases
Medexus Completes Agreement to Return US Commercialization Rights for Gleolan to NX Development Corp.
March 14, 2025
·
4 min read
1 of 510
Next
